Evidence map›Paper›PMID 32234120›Full record

Observational studyEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2020

Multi-laboratory evaluation of ReaScan TBE IgM rapid test, 2016 to 2017.

Bo Albinsson, Anu E Jääskeläinen, Kairi Värv, Mateja Jelovšek, Corine GeurtsvanKessel, Sirkka Vene, Josef D Järhult, Chantal Reusken, Irina Golovljova, Tatjana Avšič-Županc and 2 more

Open access · diamondAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. The AxBioTick Study:Microorganisms · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Bo AlbinssonDepartment of Medical Biochemistry and Microbiology, Zoonosis Science Centre, Uppsala University, Uppsala, Sweden.
Anu E JääskeläinenDepartment of Virology, University of Helsinki, Helsinki, Finland.
Kairi VärvDepartment of Medical Biochemistry and Microbiology, Zoonosis Science Centre, Uppsala University, Uppsala, Sweden.
Mateja JelovšekInstitute for Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Corine GeurtsvanKesselWHO Collaborating Centre for Arbovirus and Viral Haemorrhagic Fever Reference and Research, Department of Virology, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Sirkka VeneDepartment of Medical Biochemistry and Microbiology, Zoonosis Science Centre, Uppsala University, Uppsala, Sweden.
Josef D JärhultDepartment of Medical Sciences, Zoonosis Science Centre, Uppsala University, Uppsala, Sweden.
Chantal ReuskenCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Irina GolovljovaDepartment of Medical Biochemistry and Microbiology, Zoonosis Science Centre, Uppsala University, Uppsala, Sweden.
Tatjana Avšič-ŽupancInstitute for Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Olli VapalahtiDepartment of Virology, University of Helsinki, Helsinki, Finland.
Åke LundkvistDepartment of Medical Biochemistry and Microbiology, Zoonosis Science Centre, Uppsala University, Uppsala, Sweden.
Uppsala University · SEUniversity of Ljubljana · SIErasmus University Rotterdam · NLHospital District of Helsinki and Uusimaa · FINational Institute for Public Health and the Environment · NLUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundTick-borne encephalitis (TBE) is a potentially severe neurological disease caused by TBE virus (TBEV). In Europe and Asia, TBEV infection has become a growing public health concern and requires fast and specific detection.AimIn this observational study, we evaluated a rapid TBE IgM test, ReaScan TBE, for usage in a clinical laboratory setting.MethodsPatient sera found negative or positive for TBEV by serological and/or molecular methods in diagnostic laboratories of five European countries endemic for TBEV (Estonia, Finland, Slovenia, the Netherlands and Sweden) were used to assess the sensitivity and specificity of the test. The patients' diagnoses were based on other commercial or quality assured in-house assays, i.e. each laboratory's conventional routine methods. For specificity analysis, serum samples from patients with infections known to cause problems in serology were employed. These samples tested positive for e.g. Epstein-Barr virus, cytomegalovirus and

Indexed as

Antibodies, ViralEncephalitis, Tick-BorneEncephalitis Viruses, Tick-BorneFemaleHumansImmunoenzyme TechniquesImmunoglobulin MMalePredictive Value of TestsSensitivity and SpecificityAntibodies, ViralImmunoglobulin MEuropeflavivirusrapid diagnosticsserologyTick-borne encephalitis virus

Identifiers

PMID32234120
PMCPMC7118343
OpenAlexW3013705874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.